Jonathan Kantor1, Deborah E Kantor. 1. North Florida Dermatology Associates, 1551 Riverside Ave, Jacksonville, FL 32204, USA. jonkantor@gmail.com
Abstract
OBJECTIVE: To determine the proportion of patients in a private dermatology practice in whom melanoma was detected but was not the presenting complaint. DESIGN: Retrospective analytical case series. SETTING: Private dermatology practice in Florida, from July 2005 through October 2008. Patients Patients with 126 melanomas, of which 51 were invasive and 75 were melanomas in situ. MAIN OUTCOME MEASURES: Proportion of melanomas detected as a result of patient complaint vs proportion determined by dermatologist-conducted full-body skin examination (FBSE). As a secondary analysis, we used logistic regression odds ratios (ORs) of association to examine whether dermatologist detection rather than patient complaint was associated with detecting thinner melanomas. A post hoc analysis was performed using a thickness cutoff of 1.0 mm to define a deep melanoma. RESULTS: Overall, 56.3% (95% confidence interval [CI], 47.6%-65.1%) of melanomas were found by the dermatologist and were not part of the presenting complaint. Of melanomas in situ, 60.0% (95% CI, 48.7%-71.3%) were dermatologist detected. Dermatologist detection was significantly associated with thinner melanomas, with an OR of 0.42 (P = .04). We found a significant association between thinner melanomas as a group (thickness <1 mm) and dermatologist detection, with a logistic regression OR of 5.0 (95% CI, 1.0-25.3). CONCLUSIONS: Most melanomas detected in a general-practice dermatology setting were found as a result of dermatologist-initiated FBSE, not patient complaint. We found that dermatologist detection was associated with thinner melanomas and an increasing likelihood of the melanoma being in situ.
OBJECTIVE: To determine the proportion of patients in a private dermatology practice in whom melanoma was detected but was not the presenting complaint. DESIGN: Retrospective analytical case series. SETTING: Private dermatology practice in Florida, from July 2005 through October 2008. PatientsPatients with 126 melanomas, of which 51 were invasive and 75 were melanomas in situ. MAIN OUTCOME MEASURES: Proportion of melanomas detected as a result of patient complaint vs proportion determined by dermatologist-conducted full-body skin examination (FBSE). As a secondary analysis, we used logistic regression odds ratios (ORs) of association to examine whether dermatologist detection rather than patient complaint was associated with detecting thinner melanomas. A post hoc analysis was performed using a thickness cutoff of 1.0 mm to define a deep melanoma. RESULTS: Overall, 56.3% (95% confidence interval [CI], 47.6%-65.1%) of melanomas were found by the dermatologist and were not part of the presenting complaint. Of melanomas in situ, 60.0% (95% CI, 48.7%-71.3%) were dermatologist detected. Dermatologist detection was significantly associated with thinner melanomas, with an OR of 0.42 (P = .04). We found a significant association between thinner melanomas as a group (thickness <1 mm) and dermatologist detection, with a logistic regression OR of 5.0 (95% CI, 1.0-25.3). CONCLUSIONS: Most melanomas detected in a general-practice dermatology setting were found as a result of dermatologist-initiated FBSE, not patient complaint. We found that dermatologist detection was associated with thinner melanomas and an increasing likelihood of the melanoma being in situ.
Authors: June K Robinson; Namita Jain; Ashfaq A Marghoob; William McGaghie; Michael MacLean; Pedram Gerami; Brittney Hultgren; Rob Turrisi; Kimberly Mallett; Gary J Martin Journal: J Gen Intern Med Date: 2018-02-05 Impact factor: 5.128
Authors: Richard G Roetzheim; Ji-Hyun Lee; Jeanne M Ferrante; Eduardo C Gonzalez; Ren Chen; Kate J Fisher; Kymia Love-Jackson; Ellen P McCarthy Journal: J Am Board Fam Med Date: 2013 Nov-Dec Impact factor: 2.657
Authors: Joel A Wolf; Jacqueline F Moreau; Oleg Akilov; Timothy Patton; Joseph C English; Jonhan Ho; Laura K Ferris Journal: JAMA Dermatol Date: 2013-04 Impact factor: 10.282
Authors: Bridget Grahmann Parsons; Lisa H Gren; Sara E Simonsen; Garrett Harding; Douglas Grossman; Yelena P Wu Journal: J Community Health Date: 2018-04
Authors: Mary K Tripp; Meg Watson; Sophie J Balk; Susan M Swetter; Jeffrey E Gershenwald Journal: CA Cancer J Clin Date: 2016-05-27 Impact factor: 508.702